FDA issued a Warning Letter to Altaire Pharmaceuticals, Inc. on 3/12/2020 as a result of this inspection.
483 Altaire Pharmaceuticals Apr 2019

483 Altaire Pharmaceuticals Apr 2019

Bijoy Panicker FDA, Avital Shimanovich FDA$119.00 - Available Now

FDA investigators audited the Altaire Pharmaceuticals - Aquebogue, NY, United States facility and issued inspectional observations (via FDA 483) on 19 Apr 2019.

Product details

  • Category: Animal Drugs & Feeds / Human Drugs
  • Inspection end: 19 Apr 2019
  • Location: Aquebogue, United States
  • FEI: 1000119582
Add To Cart